These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21309615)

  • 21. Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials.
    Müller MJ; Szegedi A
    J Clin Psychopharmacol; 2002 Jun; 22(3):318-25. PubMed ID: 12006903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.
    Backhouse ME
    Pharmacoeconomics; 2002; 20(15):1061-77. PubMed ID: 12456201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of ignoring population heterogeneity when Markov models are used in cost-effectiveness analysis.
    Zaric GS
    Med Decis Making; 2003; 23(5):379-96. PubMed ID: 14570296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical primer: sample size and power calculations-why, when and how?
    Hickey GL; Grant SW; Dunning J; Siepe M
    Eur J Cardiothorac Surg; 2018 Jul; 54(1):4-9. PubMed ID: 29757369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimum sample size allocation to minimize cost or maximize power for the two-sample trimmed mean test.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):283-98. PubMed ID: 18157920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size calculation in cost-effectiveness cluster randomized trials: optimal and maximin approaches.
    Manju MA; Candel MJ; Berger MP
    Stat Med; 2014 Jul; 33(15):2538-53. PubMed ID: 25019136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An opportunity cost approach to sample size calculation in cost-effectiveness analysis.
    Gafni A; Walter SD; Birch S; Sendi P
    Health Econ; 2008 Jan; 17(1):99-107. PubMed ID: 17497751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study design in clinical research: sample size estimation and power analysis.
    Lerman J
    Can J Anaesth; 1996 Feb; 43(2):184-91. PubMed ID: 8825545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Power and sample size for survival analysis under the Weibull distribution when the whole lifespan is of interest.
    Heo M; Faith MS; Allison DB
    Mech Ageing Dev; 1998 May; 102(1):45-53. PubMed ID: 9663791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal sample size allocation for Welch's test in one-way heteroscedastic ANOVA.
    Shieh G; Jan SL
    Behav Res Methods; 2015 Jun; 47(2):374-83. PubMed ID: 24903689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian sample size determination for cost-effectiveness studies with censored data.
    Beavers DP; Stamey JD
    PLoS One; 2018; 13(1):e0190422. PubMed ID: 29304143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian assessment of sample size for clinical trials of cost-effectiveness.
    O'Hagan A; Stevens JW
    Med Decis Making; 2001; 21(3):219-30. PubMed ID: 11386629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fundamentals of estimating sample size.
    Malone HE; Nicholl H; Coyne I
    Nurse Res; 2016 May; 23(5):21-5. PubMed ID: 27188569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient and flexible simulation-based sample size determination for clinical trials with multiple design parameters.
    Wilson DT; Hooper R; Brown J; Farrin AJ; Walwyn RE
    Stat Methods Med Res; 2021 Mar; 30(3):799-815. PubMed ID: 33267735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size determination and power analysis using the G*Power software.
    Kang H
    J Educ Eval Health Prof; 2021; 18():17. PubMed ID: 34325496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD; Peduzzi PN
    Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.